Blood Product Trial Had Disproportionate Amount Of Minority Subjects

Thirteen of the 20 cities in which a clinical trial was conducted for an artificial blood substitute had minority populations greater than that of the nation as a whole.

Leave a Reply

You must be logged in to post a comment.